The price of Aptevo Therapeutics Inc (NASDAQ: APVO) closed at $3.72 in the last session, up 2.48% from day before closing price of $3.63. In other words, the price has increased by $+0.0900 from its previous closing price. On the day, 694227 shares were traded.
Ratios:
We take a closer look at APVO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.44.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 2.56M and an Enterprise Value of -8.94M.
Stock Price History:
Over the past 52 weeks, APVO has reached a high of $91.96, while it has fallen to a 52-week low of $3.28. The 50-Day Moving Average of the stock is 5.7182, while the 200-Day Moving Average is calculated to be 17.2667.
Shares Statistics:
According to the various share statistics, APVO traded on average about 111.37K shares per day over the past 3-months and 181.91k shares per day over the past 10 days. A total of 0.67M shares are outstanding, with a floating share count of 0.67M. Insiders hold about 0.80% of the company’s shares, while institutions hold 6.57% stake in the company. Shares short for APVO as of Mar 15, 2024 were 28.86k with a Short Ratio of 0.26, compared to 446 on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.28% and a Short% of Float of 4.31%.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$11.59 for the current quarter, with a high estimate of -$11.59 and a low estimate of -$11.59, while EPS last year was $17.16. The consensus estimate for the next quarter is -$11.17, with high estimates of -$11.17 and low estimates of -$11.17.
Analysts are recommending an EPS of between -$31.5 and -$31.5 for the fiscal current year, implying an average EPS of -$31.5. EPS for the following year is -$10.5, with 1 analysts recommending between -$10.5 and -$10.5.
